Dr. Olson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10101 Park Rowe Ave
Suite 200
Baton Rouge, LA 70810Phone+1 225-769-2200Fax+1 225-768-2161
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 1997 - 1999
- University of RochesterResidency, Neurology, 1994 - 1997
- University of Tennessee College of Medicine at ChattanoogaInternship, Transitional Year, 1993 - 1994
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1993
Certifications & Licensure
- LA State Medical License 1999 - 2025
- NY State Medical License 1997 - 2000
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Roles: Contact
Publications & Presentations
PubMed
- 66 citationsPhase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors.Luis H. Camacho, Jon D. Olson, William P. Tong, Charles W. Young, David R. Spriggs
Investigational New Drugs. 2006-10-20 - 169 citationsA phase II trial of temozolomide for patients with recurrent or progressive brain metastases.Lauren E. Abrey, Jon D. Olson, Jeffrey J. Raizer, Michelle Mack, Ann Rodavitch
Journal of Neuro-Oncology. 2001-07-01 - 287 citationsLong-term outcome of low-grade oligodendroglioma and mixed glioma.Jon D. Olson, Elyn Riedel, Lisa M. DeAngelis
Neurology. 2000-04-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: